Eloxx Pharmaceuticals eloxxpharma.com


Public lists: Pharma Startups (4732)

Eloxx Pharmaceuticals (NASDAQ:ELOX) is a clinical stage company developing therapeutics for genetic diseases caused by non-sense mutations.

Eloxx Pharmaceuticals (NASDAQ:ELOX) is a clinical stage company developing therapeutics for genetic diseases caused by non-sense mutations.

Company (IPO / Went public)

Phone: +972 8 8505664

Fax:

10 Prof. Menachem Plaut Street

Rehovot, 7670621
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Eloxx Pharmaceuticals $38M Dec 22, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Eloxx Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Use of aminoglycoside analogs in the treatment of rett syndrome Jun 04, 2015 Application